{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T14:39:30Z","timestamp":1724423970348},"reference-count":45,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T00:00:00Z","timestamp":1338336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clinical case reports have suggested that specific bacterial infections are associated with certain non\u2010Hodgkin lymphoma (NHL) subtypes. Epidemiological case\u2013control studies have been conducted using antibiotics as a proxy for bacterial infections, but with inconclusive results. The aim of this study was, in a cohort design, based on the unique nationwide Danish registers, to investigate the association between use of antibiotics and the risk of NHL subtypes. On the basis of the Civil Registration System, we established a cohort of the entire adult (\u226515 years) Danish population. Information on use of antibiotics came from the Danish Drug Prescription Registry and lymphoma diagnosis from the Danish Cancer Registry. Associations were assessed by adjusted rate ratios (RRs). In total, 13,602 patients were diagnosed with one of the NHL subtypes during 51.6 million person\u2010years of follow\u2010up (1995\u20132008). We observed positive associations between use of antibiotics and plasma cell myeloma [RR = 1.11, 95% confidence intervals (CIs) = 1.00\u20131.24], chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL) (RR = 1.32, 95% CI = 1.20\u20131.45), mantle cell lymphoma (MCL) (RR = 1.40, 95% CI = 1.04\u20131.88) and anaplastic large T\u2010cell lymphoma (ALCL) (RR = 1.83, 95% CI = 1.00\u20133.36). Among these, the increased risk of CLL\/SLL, MCL and ALCL, respectively, did not vary by years since use, and only the risk of CLL\/SLL risk differed by number of prescriptions. While causality could not be established in our study, an intriguing positive long\u2010term association between antibiotic use and CLL\/SLL risk was observed. To what extent these findings indicate a role for bacteria in lymphoma pathogenesis requires further investigation.<\/jats:p>","DOI":"10.1002\/ijc.27626","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T11:17:43Z","timestamp":1336043863000},"source":"Crossref","is-referenced-by-count":7,"title":["Antibiotic use and risk of non\u2010hodgkin lymphomas"],"prefix":"10.1002","volume":"131","author":[{"given":"M.\u2010L.H.","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hjalgrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"M\u00f8lgaard\u2010Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wohlfahrt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Melbye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,5,30]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04046-0"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91408-E"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405053301803"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(02)00651-4"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)80405-7"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(00)80233-6"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190410001683723"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-109611"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031887"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh102"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.083"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj373"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22843"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205"},{"key":"e_1_2_5_16_2","first-page":"5465s","article-title":"Primary immunodeficiencies: genetic risk factors for lymphoma","volume":"52","author":"Filipovich AH","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-56352-2_8"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.051953"},{"key":"e_1_2_5_19_2","first-page":"5510s","article-title":"Prior medication use and health history as risk factors for non\u2010Hodgkin's lymphoma: preliminary results from a case\u2010control study in Los Angeles County","volume":"52","author":"Bernstein L","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11356"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi311"},{"key":"e_1_2_5_22_2","first-page":"5736","article-title":"Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow\u2010up","volume":"49","author":"Selby JV","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604127"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-044008"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07849.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-121285"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2001.d01-149.x"},{"key":"e_1_2_5_28_2","first-page":"535","article-title":"The Danish Cancer Registry\u2014history, content, quality and use","volume":"44","author":"Storm HH","year":"1997","journal-title":"Dan Med Bull"},{"key":"e_1_2_5_29_2","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissue","author":"IARC","year":"2008"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2003.50082"},{"key":"e_1_2_5_31_2","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression modeling strategies with applications to linear models, logistic regression, and survival analyses","author":"Harrel FE","year":"2001"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2008.04.003"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009708"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20891"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr127"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2009.02083.x"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06859.x"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg004"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-237651"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806122"},{"key":"e_1_2_5_41_2","article-title":"Monoclonal gammopathy of undetermined significance and risk of infections: a population\u2010based study","author":"Kristinsson SY","journal-title":"Haematologica"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0300"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj004"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr273"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22719"},{"key":"e_1_2_5_46_2","volume-title":"L\u00e6gemiddelstyrelsen, Medicinal Product Statistics, 2006\u20102010","year":"2011"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.27626","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.27626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:30:54Z","timestamp":1697502654000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.27626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,30]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.1002\/ijc.27626"],"URL":"https:\/\/doi.org\/10.1002\/ijc.27626","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,30]]}}}